Título : | CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival |
Autor(es) : | Ferrer, Gerardo Palacios, Florencia Chiu, Pui Yan Wong, Kelly Bueno-Costa, Alberto Barrientos, Jacqueline C. Kolitz, Jonathan E. Allen, Steven L. Rai, Kanti R. Chen, Shih-Shih Barbara, Sherry Chiorazzi, Nicholas |
Fecha de publicación : | 22-nov-2024 |
Tipo de publicación: | Artículo |
Versión: | Aceptado |
Publicado por: | Nature |
Publicado en: | Leukemia |
Areas del conocimiento : | Ciencias Naturales y Exactas Ciencias Biológicas Bioquímica y Biología Molecular |
Otros descriptores : | Cancer immunology leukemia |
Resumen : | Patients with chronic lymphocytic leukemia (CLL) exhibit clinical findings suggesting an altered immune system, with an increased risk of infection and the development of other cancers and various autoimmune phenomena. These associations are thought to be orchestrated in part by the interactions of leukemic cells with normal cells and elements in tissues, the latter referred to as the tumor microenvironment (TME). Notably, these interactions support the survival and expansion of CLL cells. Most well studied is the impact of the leukemic cells on T cells, leading to alterations in T-cell subset composition, surface membrane molecule expression, immune-synapse formation, and migration, along with functional changes such as exhaustion. Nevertheless, the molecular mechanisms by which differentiation of naive T (Tn) cells to various memory T-cell subsets occurs in CLL and the effects of imbalances of the process on leukemic B-cell survival and disease progression are not fully understood. Our results suggest a previously unrecognized positive loop involving IL-22-producing T cells, CLL B cells, and T cells in the TME that contributes to the maintenance of the leukemic clone and inuences patient outcomes. Deciphering this complex interplay within the CLL TME might provide insights that could inform future therapeutic strategies. |
URI / Handle: | https://hdl.handle.net/20.500.12381/3867 |
DOI: | https://doi.org/10.1038/s41375-024-02463-9 |
Institución responsable del proyecto: | Instituto de investigación en Cáncer, Josep Carreras, España Institut Pasteur de Montevideo The Feinstein Institutes For Medical Research, Estados Unidos Centro de Investigación Biomédica en Red Cáncer (CIBERONC), España Department of Medicine, Northwell Health, Estados Unidos Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Estados Unidos Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Estados Unidos |
Financiadores: | Fundación Científica AECC NIH National Cancer Institute CLL Global Research Foundation The Nash Family Foundation The Muriel Fusfeld Foundation Jean Walton Fund for Leukemia, Lymphoma, and Myeloma Research. |
Nivel de Acceso: | Acceso abierto |
Licencia CC: | Reconocimiento-NoComercial 4.0 Internacional. (CC BY-NC) |
Aparece en las colecciones: | Institut Pasteur de Montevideo |
Archivos en este ítem:
archivo | Descripción | Tamaño | Formato | ||
---|---|---|---|---|---|
41375_2024_Article_2463.pdf | Descargar | 830.67 kB | Adobe PDF |
Las obras en REDI están protegidas por licencias Creative Commons.
Por más información sobre los términos de esta publicación, visita:
Reconocimiento-NoComercial 4.0 Internacional. (CC BY-NC)